Skip to content
Disclosery

XPONANCE LLC

Follow

13F filer, CIK 1637541, PHILADELPHIA, PA

XPONANCE LLC reported $11,968,127,825 across 1,508 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 39.3% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-25-005124

Period
2025-06-30
Reported value
$12B
Holdings
1,508
Top 10 weight
39.3%
New
108
Sold out
45

Largest buys vs the previous quarter

SecurityShares changeApprox. value
NVDAadded+269,132$42.5M
AAPLadded+198,364$40.7M
MSFTadded+80,222$39.9M
GEadded+87,732$22.6M
ABBVadded+107,804$20M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AMZNreduced-100,710-$22.1M
GOOGLreduced-123,836-$21.8M
GOOGreduced-107,026-$19M
CRMreduced-59,086-$16.1M
MRKreduced-195,665-$15.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001085146-25-005124, largest first. % of portfolio is the value over $11,968,127,825, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,290 shares; 2024Q4: 12,393 shares; 2025Q1: 13,116 shares; 2025Q2: 13,490 shares 13,490$17.1K<0.01%+374Timeline
PGENPRECIGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 11,546 shares 11,546$16.4K<0.01%newTimeline
DDD3D SYS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 10,582 shares; 2025Q2: 10,165 shares 10,165$15.7K<0.01%-417Timeline
ESPRESPERION THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,086 shares; 2024Q4: 13,231 shares; 2025Q1: 13,941 shares; 2025Q2: 15,471 shares 15,471$15.2K<0.01%+1,530Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 11,805 shares 11,805$13.3K<0.01%newTimeline
HYLNHYLIION HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 11,201 shares; 2025Q1: 11,440 shares; 2025Q2: 10,047 shares 10,047$13.3K<0.01%-1,393Timeline
IRWDIRONWOOD PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 11,310 shares; 2025Q1: 11,493 shares; 2025Q2: 12,339 shares 12,339$8.85K<0.01%+846Timeline
WOLFSPEED INCWOLFSPEED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 12,380 shares 12,380$4.94K<0.01%new

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DISCOVER FINL SVCSDISCOVER FINL SVCS35,768$6.11Mshares
INTRA-CELLULAR THERAPIES INCINTRA-CELLULAR THERAPIES INC14,093$1.86Mshares
UNITED STATES STL CORP NEWUNITED STATES STL CORP NEW26,199$1.11Mshares
BERRY GLOBAL GROUP INCBERRY GLOBAL GROUP INC13,964$975Kshares
BEACON ROOFING SUPPLY INCBEACON ROOFING SUPPLY INC5,048$624Kshares
ROCKET LAB USA INCROCKET LAB USA INC27,119$485Kshares
SLVMSYLVAMO CORP5,807$389Kshares
NORDSTROM INCNORDSTROM INC15,907$389Kshares
VKTXVIKING THERAPEUTICS INC14,470$349Kshares
TDCTERADATA CORP DEL12,899$290Kshares
SAMBOSTON BEER INC1,200$287Kshares
CASHPATHWARD FINANCIAL INC3,903$285Kshares
FIVNFIVE9 INC9,835$267Kshares
NCNONCINO INC8,954$246Kshares
DXCDXC TECHNOLOGY CO14,032$239Kshares
H&E EQUIPMENT SERVICES INCH&E EQUIPMENT SERVICES INC2,444$232Kshares
HPHELMERICH & PAYNE INC8,294$217Kshares
ACLXARCELLX INC3,278$215Kshares
CCOICOGENT COMM HOLDINGS INC3,497$214Kshares
TNETTRINET GROUP INC2,613$207Kshares
WDWALKER & DUNLOP INC2,423$207Kshares
AGOASSURED GUARANTY LTD2,347$207Kshares
XSWSPDR SERIES TRUST1,292$207Kshares
VCYTVERACYTE INC6,860$203Kshares
NAVINAVIENT CORPORATION15,425$195Kshares
DHTDHT HOLDINGS INC10,113$106Kshares
TALOTALOS ENERGY INC10,856$106Kshares
TXG10X GENOMICS INC12,010$105Kshares
WTWISDOMTREE INC10,078$89.9Kshares
AUPHAURINIA PHARMACEUTICALS INC10,146$81.6Kshares
OPENOPENDOOR TECHNOLOGIES INC48,117$49.1Kshares
CCOCLEAR CHANNEL OUTDOOR HLDGS25,448$28.2Kshares
CHARGEPOINT HLDGS INCCHARGEPOINT HLDGS INC33,434$20.2Kshares
URGUR-ENERGY INC26,147$17.6Kshares
SMRTSMARTRENT INC13,274$16.1Kshares
GRAFTECH INTL LTDGRAFTECH INTL LTD18,172$15.9Kshares
OCGNOCUGEN INC18,951$13.4Kshares
IAUXI-80 GOLD CORP22,498$13.1Kshares
REIRING ENERGY INC10,337$11.9Kshares
Leslie's IncLeslie's Inc13,025$9.58Kshares
NEKTAR THERAPEUTICSNEKTAR THERAPEUTICS12,190$8.29Kshares
CHGGCHEGG INC10,009$6.4Kshares
LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INC11,269$6.06Kshares
LCTXLINEAGE CELL THERAPEUTICS IN12,875$5.81Kshares
X4 PHARMACEUTICALS INCX4 PHARMACEUTICALS INC11,046$2.61Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-25-005124 base2025-08-14acceptance time not in the bulk data set